Pulmonary Hypertension News

June 21, 2021June 21, 2021

FDA Gives PulmoSIM’s PT001 Orphan Drug Designation for PAH

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to PT001, an investigational treatment for pulmonary arterial hypertension (PAH). The FDA gives this designation to therapies with the ... Read more

June 18, 2021June 18, 2021

Tyvaso DPI Earns FDA Priority Review Status

Pulmonary Hypertension News

The U.S. Food and Drug Administration (FDA) has granted priority review status to the application seeking approval of Tyvaso DPI — a dry powder inhaled formulation of treprostinil — for ... Read more

June 17, 2021June 17, 2021

Get Ready for NORD’s Patient and Family Forum, Set for June 26-27

COVID-19 News, Pulmonary Hypertension News

Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual Living Rare Living Stronger Patient and Family Forum, hosted by the ... Read more

June 16, 2021June 16, 2021

Research Sheds Light on Potential Immune Changes in IPAH

Pulmonary Hypertension News

A combination of lung injury and increased activation of B-cells — immune cells responsible for antibody production — was sufficient to promote symptoms of pulmonary hypertension (PH) in mice, a study ... Read more

June 14, 2021June 14, 2021

Prostacyclin Therapy, Expert Care Help in Pregnancy With PAH

Pulmonary Hypertension News

Despite a high-risk of serious complications, 10 women with moderate to severe pulmonary arterial hypertension (PAH) had a successful pregnancy and delivery, according to a single center study. The patients ... Read more

June 11, 2021June 11, 2021

Text-based Intervention Helped Increase Physical Activity

Pulmonary Hypertension News

A three-month, unsupervised health intervention based on a commercial activity tracker and motivational texts significantly increased daily step counts and improved quality of life in adults with pulmonary arterial hypertension (PAH), ... Read more

June 9, 2021June 9, 2021

PAPP, Measure of Cardiac Health, May Help to Spot Heart Failure Risk

Pulmonary Hypertension News

A new metric for assessing cardiac health, called pulmonary artery proportional pulse pressure or PAPP, could help to identify people at high risk of hospitalization or death due to pulmonary ... Read more

June 8, 2021June 8, 2021

Rare 2030 Action Campaign Pushing for European Plan for Rare Diseases

Pulmonary Hypertension News

Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for rare diseases to ensure that none of the 30 million people in ... Read more

June 7, 2021June 7, 2021

Monotherapy Likely Enough to Help Manage Atypical PAH, Study Says

Pulmonary Hypertension News

Treatment with a single medication (monotherapy) may be sufficient to help manage people with “atypical” pulmonary arterial hypertension (PAH), according to an analysis from four clinical centers in Germany. One-year ... Read more

June 4, 2021June 4, 2021

LIQ861 Inhalation Therapy for PAH Again Under FDA Review

Pulmonary Hypertension News

The U.S. Food and Drug Administration (FDA) has accepted an updated application asking that the dry-powder inhalation therapy LIQ861 (treprostinil) be approved to treat pulmonary arterial hypertension (PAH). Liquidia Corporation, the ... Read more

June 3, 2021June 3, 2021

Advocates Can Try for Grants Ahead of Rare Disease Week on Capitol Hill

Pulmonary Hypertension News

Ahead of this year’s Rare Disease Week on Capitol Hill, held virtually July 14–22, the EveryLife Foundation will award grants to top advocates of rare disease organizations who participate in ... Read more

June 2, 2021June 2, 2021

Low Risk of PH With Pregnancy Linked to Better Overall Heart Health

Pulmonary Hypertension News

Pregnant women with high pressure in the pulmonary artery of the heart, but who are not considered at risk of pulmonary hypertension (PH), are likely to also be at lower ... Read more

May 28, 2021May 28, 2021

‘Blueprint’ of Healthy Lung Cells May Guide Research Into Lung Disease

Pulmonary Hypertension News

Scientists have created a new “cellular blueprint” of healthy lung cells that provides a reference against which tissue from lungs affected by conditions like pulmonary hypertension (PH) can be compared. ... Read more

May 26, 2021May 26, 2021

Generic Treprostinil Available as Under-the-skin Injection

Pulmonary Hypertension News

Sandoz‘s generic treprostinil injection now is available for subcutaneous (under-the-skin) administration to treat pulmonary arterial hypertension (PAH), the company announced in a press release. Treprostinil first was approved to treat ... Read more

May 24, 2021May 24, 2021

Repurposed Trifluoperazine (TFP) May Be Effective PAH Therapy

Pulmonary Hypertension News

Trifluoperazine or TFP, an approved schizophrenia medication, also may be effective in the treatment of pulmonary arterial hypertension (PAH), a preclinical study suggests. In rat models of PAH, trifluoperazine was ... Read more